IOL CHEMICALS & PHARM. | DENIS CHEM LAB | IOL CHEMICALS & PHARM./ DENIS CHEM LAB |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.2 | 22.6 | 58.1% | View Chart |
P/BV | x | 1.5 | 2.9 | 52.0% | View Chart |
Dividend Yield | % | 1.0 | 1.3 | 78.0% |
IOL CHEMICALS & PHARM. DENIS CHEM LAB |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
DENIS CHEM LAB Mar-23 |
IOL CHEMICALS & PHARM./ DENIS CHEM LAB |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 108 | 496.0% | |
Low | Rs | 272 | 49 | 553.3% | |
Sales per share (Unadj.) | Rs | 377.6 | 115.9 | 325.9% | |
Earnings per share (Unadj.) | Rs | 23.7 | 5.7 | 418.5% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 11.3 | 279.5% | |
Dividends per share (Unadj.) | Rs | 4.00 | 2.00 | 200.0% | |
Avg Dividend yield | % | 1.0 | 2.5 | 38.9% | |
Book value per share (Unadj.) | Rs | 256.8 | 52.1 | 493.3% | |
Shares outstanding (eoy) | m | 58.71 | 13.88 | 423.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0.7 | 157.7% | |
Avg P/E ratio | x | 17.1 | 13.9 | 122.8% | |
P/CF ratio (eoy) | x | 12.8 | 7.0 | 183.9% | |
Price / Book Value ratio | x | 1.6 | 1.5 | 104.2% | |
Dividend payout | % | 16.9 | 35.3 | 47.8% | |
Avg Mkt Cap | Rs m | 23,743 | 1,092 | 2,174.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 130 | 1,291.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 1,608 | 1,378.4% | |
Other income | Rs m | 256 | 6 | 4,326.0% | |
Total revenues | Rs m | 22,427 | 1,614 | 1,389.2% | |
Gross profit | Rs m | 2,257 | 188 | 1,201.7% | |
Depreciation | Rs m | 462 | 78 | 590.7% | |
Interest | Rs m | 165 | 6 | 2,569.4% | |
Profit before tax | Rs m | 1,887 | 109 | 1,728.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 31 | 1,620.1% | |
Profit after tax | Rs m | 1,391 | 79 | 1,770.2% | |
Gross profit margin | % | 10.2 | 11.7 | 87.2% | |
Effective tax rate | % | 26.2 | 28.0 | 93.7% | |
Net profit margin | % | 6.3 | 4.9 | 128.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 592 | 1,631.8% | |
Current liabilities | Rs m | 5,025 | 241 | 2,087.3% | |
Net working cap to sales | % | 20.9 | 21.9 | 95.8% | |
Current ratio | x | 1.9 | 2.5 | 78.2% | |
Inventory Days | Days | 43 | 6 | 716.0% | |
Debtors Days | Days | 8 | 709 | 1.2% | |
Net fixed assets | Rs m | 11,017 | 402 | 2,740.1% | |
Share capital | Rs m | 587 | 139 | 423.1% | |
"Free" reserves | Rs m | 14,490 | 584 | 2,481.8% | |
Net worth | Rs m | 15,077 | 723 | 2,086.4% | |
Long term debt | Rs m | 0 | 9 | 0.0% | |
Total assets | Rs m | 20,684 | 994 | 2,079.9% | |
Interest coverage | x | 12.5 | 18.0 | 69.1% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 1.1 | 1.6 | 66.3% | |
Return on assets | % | 7.5 | 8.5 | 88.0% | |
Return on equity | % | 9.2 | 10.9 | 84.8% | |
Return on capital | % | 13.6 | 15.8 | 86.2% | |
Exports to sales | % | 26.7 | 2.0 | 1,357.3% | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | 32 | 18,706.9% | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 32 | 18,706.9% | |
Fx outflow | Rs m | 6,052 | 0 | - | |
Net fx | Rs m | -122 | 32 | -383.9% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 163 | 748.3% | |
From Investments | Rs m | -1,200 | -112 | 1,075.8% | |
From Financial Activity | Rs m | -41 | -40 | 102.6% | |
Net Cashflow | Rs m | -18 | 12 | -156.1% |
Indian Promoters | % | 48.2 | 39.0 | 123.6% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | - | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 61.0 | 84.9% | |
Shareholders | 130,003 | 4,794 | 2,711.8% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | DENIS CHEM LAB | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.18% | -1.09% | -0.44% |
1-Month | -4.51% | 11.85% | 2.15% |
1-Year | -4.09% | 95.81% | 49.82% |
3-Year CAGR | -12.01% | 56.76% | 14.21% |
5-Year CAGR | 15.35% | 16.76% | 19.19% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the DENIS CHEM LAB share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of DENIS CHEM LAB the stake stands at 39.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of DENIS CHEM LAB.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
DENIS CHEM LAB paid Rs 2.0, and its dividend payout ratio stood at 35.3%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of DENIS CHEM LAB.
For a sector overview, read our pharmaceuticals sector report.
After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.